Male Reproductive System Carcinoma — Trials

Male Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 451
Recruiting: 240
Ph III recruiting: 20
Growth YoY: +1.3%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (190)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05401214	Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)	approved for marketing	—	—	Janssen Research & Development, LLCINDUSTRY	0	Jun 13, 2025	clinicaltrials
NCT04377152	Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer	approved for marketing	—	—	University of California, San FranciscoOTHER	1	Mar 1, 2021